HIV/AIDS education classes cause controversy in China

A lecture in Harbin, China, led by the Harbin Municipal Disease Prevention and Control Center that informed commercial sex workers about HIV/AIDS and other sexually transmitted infections has "sparked a strong rebuke" from some authorities and residents, Reuters reports (Reuters, 10/15).

According to the Harbin Daily, the center organized the two-hour class for more than 50 women involved in the city's commercial sex industry to teach them about HIV and the importance of using condoms correctly.

The session also allowed the sex workers to discuss their occupation openly, Xinhua/China Daily reports.

After the lecture, organizers distributed boxes of condoms at no cost to the participants and gave them the center's phone number (Xinhua/China Daily, 10/16).

The Beijing News reported that local police called the lecture "unacceptable" (Reuters, 10/15).

Wen Yinghcun, director of Harbin's disease prevention and control center, said that he had been warned by local officials that police might object to the initiatives but that the majority of people and government officials have supported the programs, the South China Morning Post reports.

According to a survey conducted by a Chinese Web site, sina.com, 77% of 5,000 respondents supported the classes and 20% opposed them.

"Only 15% of sex workers in the city use condoms regularly, and most of them don't even know exactly what AIDS is," Wen said (Wu, South China Morning Post, 10/16).

"If we neglect this group of people, it's irresponsible," he added (Xinhua/China Daily, 10/16).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug